Search results for "Algorithm"

showing 10 items of 4887 documents

How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016

2020

Purpose. To describe intravitreal anti-VEGF drug and dexamethasone use in four Italian regions. Methods. Four regional claims databases were used to measure drug prevalence, compare dosing intervals to those recommended in the summary of product characteristics (SPC), and identify switchers. Bilateral treatment and diabetic macular edema (DME) coding algorithms were validated, linking claims with a sample of prospectively collected ophthalmological data. Results. Overall, 41,836 patients received ≥1 study drug in 2010–2016 (4.8 per 10,000 persons). In 2016, anti-VEGF drug use ranged from 0.8 (Basilicata) to 5.7 (Lombardy) per 10,000 persons while intravitreal dexamethasone use ranged from 0…

MaleVascular Endothelial Growth Factor A0301 basic medicineintravitrealAngiogenesis Inhibitorsalgorithm.0302 clinical medicineMedicineSummary of Product Characteristicsmedia_commonAged 80 and overDrug ImplantsvalidationLaser CoagulationRGeneral MedicineMiddle AgedItalyanti-VEGF030220 oncology & carcinogenesisMedicineFemaleclinical dataoriginal articleResearch Articlemedicine.drugDrugmedicine.medical_specialtyArticle Subjectmedia_common.quotation_subjectMEDLINEdexamethasonePharmacyMacular EdemaGeneral Biochemistry Genetics and Molecular BiologyInsurance Claim Review03 medical and health sciencesRanibizumabInternal medicineHumansDosingDexamethasoneAgedDiabetic RetinopathyGeneral Immunology and MicrobiologySettore MED/30 - Malattie Apparato Visivobusiness.industryclaims database030104 developmental biologydrug utilisationMacular Edema; Ranibizumab; Laser CoagulationImplantRanibizumabbusinessBioMed Research International
researchProduct

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

2019

Maleantiretroviral treatmentInfectious Disease TransmissiongenotypeHuman immunodeficiency virus (HIV)Drug ResistanceHIV InfectionsDrug resistancemedicine.disease_causeRetrospective StudieGenotypepol Gene Products Human Immunodeficiency ViruPrevalenceMedicineVerticalHIV InfectionViralpol Gene ProductsYoung adultGeneral MedicineInfectious DiseasesItalyMutation (genetic algorithm)FemaleHuman Immunodeficiency VirusHumanMicrobiology (medical)AdultSettore MED/17 - Malattie InfettiveAdolescentAnti-HIV AgentsYoung AdultAcquired resistanceDrug Resistance ViralHumansvertical HIV transmissionAdolescent; Adult; Anti-HIV Agents; Drug Resistance Viral; Female; HIV Infections; HIV-1; Humans; Italy; Male; Mutation; Prevalence; Retrospective Studies; Young Adult; pol Gene Products Human Immunodeficiency Virus; Infectious Disease Transmission VerticalRetrospective StudiesHIV perinatally infectionbusiness.industryAnti-HIV AgentRetrospective cohort studyVirologyInfectious Disease Transmission VerticalLarge cohortpol Gene Products Human Immunodeficiency VirusDrug resistanceMutationHIV-1Drug resistance; HIV-1; antiretroviral treatment; genotype; vertical HIV transmissionbusiness
researchProduct

Can bayesian models play a role in dental caries epidemiology? Evidence from an application to the BELCAP data set

2012

Objectives The aim of this study was to show the potential of Bayesian analysis in statistical modelling of dental caries data. Because of the bounded nature of the dmft (DMFT) index, zero-inflated binomial (ZIB) and beta-binomial (ZIBB) models were considered. The effects of incorporating prior information available about the parameters of models were also shown. Methods The data set used in this study was the Belo Horizonte Caries Prevention (BELCAP) study (Bohning et al. (1999)), consisting of five variables collected among 797 Brazilian school children designed to evaluate four programmes for reducing caries. Only the eight primary molar teeth were considered in the data set. A data aug…

Malebounded dataBest fittingBayesian probabilityDeviance (statistics)informative priorDental CariesSettore MED/42 - Igiene Generale E ApplicataSettore MED/01 - Statistica MedicaOverdispersionPrior probabilityStatisticsHumansMedicineChildGeneral DentistryBayesian analysidmftDMF Indexbusiness.industryBelo Horizonte Caries Preventionzero-inflated betabinomialCaries epidemiologyPublic Health Environmental and Occupational HealthBayes TheoremStatistical modelRegressionzero-inflated binomialFemalebusinessAlgorithmsBrazilBayesian analysis; Belo Horizonte Caries Prevention; bounded data; dmft; informative prior; zero-inflated betabinomial; zero-inflated binomialCommunity Dentistry and Oral Epidemiology
researchProduct

Association between the HFE mutations and longevity: a study in Sardinian population

2003

Hereditary hemochromatosis is an HLA-linked inherited disease characterised by inappropriately high absorption of iron by the gastrointestinal mucosa. The cysteine-to-tyrosine substitution at codon 282 of the HFE encoding gene sequence is responsible for the disease, although other variants, as H63D and S65C, may modify the affinity of the protein for transferrin receptors. We have recently reported that C282Y mutation is significantly increased in very old (>90 years) Sicilian women, suggesting a role in attainment of longevity. In addition, an increase of H63D polymorphism was also observed in these women but the difference was not significant. To validate and extend these results we inve…

Malecongenital hereditary and neonatal diseases and abnormalitiesAgingIronLongevityPopulation geneticsTransferrin receptorBiologyPolymorphism (computer science)medicineHumansPoint MutationAlleleHemochromatosis ProteinHemochromatosisAgedAged 80 and overGeneticsPolymorphism GeneticHistocompatibility Antigens Class IMembrane Proteinsnutritional and metabolic diseasesMiddle Agedmedicine.diseaseItalyHereditary hemochromatosisMutation (genetic algorithm)CentenarianDevelopmental BiologyMechanisms of Ageing and Development
researchProduct

A novel mutation of the DHCR7 gene in a sicilian compound heterozygote with Smith-Lemli-Opitz Syndrome

2005

Introduction: Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder of cholesterol biosynthesis, resulting from deficient 7-dehydrocholesterol reductase (3β-hydroxysterol Δ7-reductase) activity, the enzyme responsible for conversion of 7-dehydrocholesterol to cholesterol. SLOS is most common among people of European descent, with a reported incidence of 1 per 20 000–60 000 newborns, depending on the diagnostic criteria and the reference population. More than 80 different mutations have been identified in several hundred patients. In Italy, SLOS appears to be a rare condition, probably because of underdiagnosis. Method: We analyzed by direct sequencing the 7-dehydrocholesterol…

Malecongenital hereditary and neonatal diseases and abnormalitiesHeterozygoteOxidoreductases Acting on CH-CH Group DonorsMutation MissenseBiologyReductaseCompound heterozygosityExonmedicineMissense mutationHumansGeneSicilyGeneticsnutritional and metabolic diseasesInfantGeneral Medicinemedicine.diseaseHuman geneticsPedigreeSmith-Lemli-Opitz SyndromeOxidoreductases Acting on CH-CH Group DonorSmith–Lemli–Opitz syndromeMutation (genetic algorithm)Human
researchProduct

Patient-reported impact of Charcot-Marie-Tooth disease: protocol for a real-world digital lifestyle study

2021

Abstract Background Charcot-Marie-Tooth disease (CMT) is a rare, chronic, progressive motor and sensory neuropathy that affects the peripheral nervous system, leading to progressive, predominantly distal muscle weakness, atrophy, sensory loss and progressive limb dysfunction. As with many rare diseases, there is a lack of patient-reported data with which to understand and address patient needs. This study aims to explore the real-world impact of CMT from the patient perspective. Methods This is a prospective, digital lifestyle study of at least 2,000 people with CMT, >18 years, resident in the following countries: France, Germany, Italy, Spain, the UK and the USA. Participants will be re…

Malecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyDemographicsDiseaseUnmet needs03 medical and health sciencesTooth disease0302 clinical medicinePhysical medicine and rehabilitationCharcot-Marie-Tooth DiseaseMedicineHumans030212 general & internal medicineobservationalPatient Reported Outcome MeasuresProspective StudiesLife StyleSelection (genetic algorithm)Protocol (science)business.industryIdentifierpatient-reported outcomesinternationalburden of illnessObservational studyFemaleNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Biochemical selection of prepubertal patients with androgen insensitivity syndrome by sex hormone-binding globulin response to the human chorionic go…

1997

Before puberty, the diagnosis of androgen insensitivity syndrome (AIS) can be difficult. We studied whether the decrease of sex hormone-binding globulin (SHBG) during the human chorionic gonadotropin (hCG) test may represent a biochemical test to select prepubertal patients with AIS. We examined prepubertal patients with AIS (n = 9, age 0.9-8.2 y), male pseudohermaphroditism not due to AIS (other-MPH) (n = 8, age 0.6-10.7 y), and control boys (n = 12, age 0.8-12.5 y). Testosterone and SHBG levels (mean +/- SD) were measured before (d 0) and after (d 5) a hCG test (1500 IU X 3 d). Testosterone levels (nmol/L) increased in all groups [AIS: from 1.5 +/- 1.2 to 22.1 +/- 11.8 (p0.001); other-MPH…

Maleendocrine systemmedicine.medical_specialtyGlobulinmedicine.drug_classDisorders of Sex DevelopmentEndocrine System DiseasesChorionic GonadotropinHuman chorionic gonadotropinSex hormone-binding globulinInternal medicineSex Hormone-Binding GlobulinmedicineHumansTestosteroneChildSelection (genetic algorithm)biologyurogenital systemPatient SelectionInfantSyndromeAndrogenmedicine.diseaseEndocrinologyReceptors AndrogenCase-Control StudiesChild PreschoolKaryotypingembryonic structuresPediatrics Perinatology and Child Healthbiology.proteinAndrogensAndrogen insensitivity syndromeGonadotropinSex Hormone Binding ProteinPediatric research
researchProduct

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit fro…

2009

Objectives: To test retrospectively the ability of four freely available rules-based expert systems to predict short- and medium-term virological outcome following an antiretroviral treatment switch in pre-treated HIV-1 patients. Methods: The HIV-1 genotype interpretation systems (GISs) HIVdb, ANRS, Rega and AntiRetroScan were tested for their accuracy in predicting response to highly active antiretroviral therapy using 8 week (n = 765) and 24 week (n = 634) follow-up standardized treatment change episodes extracted from the Italian Antiretroviral Resistance Cohort Analysis (ARCA) database. A genotypic sensitivity score (GSS) was derived for each genotype-treatment pair for the different GI…

Maleinterpretation systemHIV InfectionsDrug resistanceLogistic regressionRetrospective StudieHIV InfectionPharmacology (medical)Microbial Sensitivity TestMiddle AgedPrognosisgenotype drug resistance algorithmAlgorithmTreatment OutcomeInfectious DiseasesItalyRNA ViralFemaleCohort studyHumanMicrobiology (medical)Adultmedicine.medical_specialtyGenotypeLogistic ModelAnti-HIV AgentsPrognosiantiretroviralMicrobial Sensitivity TestsInternal medicinemedicinePotencyAnimalsHumansRetrospective StudiesPharmacologyReceiver operating characteristicbusiness.industryAnimalAnti-HIV AgentRetrospective cohort studyOdds ratiogenotype; interpretation system; antiretroviral; drug potency weightingWeightingLogistic ModelsROC CurveDrug resistanceImmunologyHIV-1businessdrug potency weighting
researchProduct

Founder-effect speciation theory: Failure of experimental corroboration

1995

The theory of founder-effect speciation proposes that colonization by very few individuals of an empty habitat favors rapid genetic changes and the evolution of a new species. We report here the results obtained in a 10-year-long and large-scale experiment with Drosophila pseudoobscura designed to test the theory. In our experimental protocol, populations are established with variable numbers of very few individuals and allowed to expand greatly for several generations until conditions of severe competition for resources are reached and the population crashes. A few random survivors are then taken to start a new population expansion and thus initiate a new cycle of founding events, populati…

Malemedia_common.quotation_subjectPopulationModels BiologicalCompetition (biology)Drosophila pseudoobscuraGenetic algorithmAnimalseducationCrosses Geneticmedia_commonRecombination Geneticeducation.field_of_studyMultidisciplinarybiologyEcologyReproductionBiological evolutionbiology.organism_classificationNew populationBiological EvolutionGenetics PopulationHabitatDrosophilaFemaleFounder effectResearch Article
researchProduct

Brachytherapy organ dose estimation using Monte Carlo simulations of realistic patient models

2018

Radiation Therapy Planning Systems (RTPS) currently used in hospitals contain algorithms based on deterministic simplifications that do not properly consider electrons lateral transport in the areas where there are changes of density, and as a result, erroneous dose predictions could be produced. According to this, the present work proposes the use of Monte Carlo method in brachytherapy planning systems, which could affect positively on the radiotherapy treatment planning, since it provides results that are more accurate and takes into account the in homogeneities density variations. This paper presents a Monte Carlo (MC) simulation of a brachytherapy prostate treatment with I-125 seeds, us…

Malemedicine.diagnostic_testComputer scienceRadiotherapy Planning Computer-Assistedmedicine.medical_treatmentBrachytherapyMonte Carlo methodBrachytherapyRadiotherapy DosageComputed tomographyRadiotherapy treatment planningBrachytherapy prostateIodine RadioisotopesDose estimationmedicineHumansSegmentationRadiation treatment planningMonte Carlo MethodAlgorithmAlgorithms2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
researchProduct